Here, we report a genome-wide analysis of multiple gene expression signatures of > 2000 molecularly-characterized primary and metastatic CRCs, that provides a new and deeper understanding of CRC oncogenic signaling and drug resistance mechanisms for which we have proposed SRC as a common targetable node. The gene discussed is SRC; the disease is colorectal carcinoma.